|

HDM SLIT-tablet (12 SQ-HDM) Clinical Trials

1 actively recruiting trial

Pipeline

Phase 3: 1

Top Sponsors

  • ALK-Abelló A/S1

Indications

  • Allergic Rhinoconjunctivitis1
  • Allergic Rhinitis1
  • Asthma1

Other1 trial

A Research Study of House Dust Mite (HDM) SLIT-tablet for the Treatment of HDM Allergy in Chinese Participants Aged 12-65
Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.